AB SCIEX Opens R&D Center In Singapore
November 6, 2013
AB SCIEX has announced the opening of a new research and development center in Singapore.
AsianScientist (Nov. 6, 2013) – AB SCIEX, a mass spectrometry company, has announced the opening of its new research and development center in Singapore.
The facility is an extension of the company’s factory in Marsiling, where its life science analytical instruments, including the AB SCIEX 6500 series and TripleTOF® series, are manufactured.
The AB SCIEX R&D Center is focused on product development and brings R&D and manufacturing closer together. AB SCIEX spends close to ten percent of its annual revenues on R&D, which is a driving force for the company’s continued innovation in LC/MS/MS (liquid chromatography/tandem mass spectrometry).
The company has also invested in an application support and training facility in the Biopolis, which is Singapore’s biomedical research hub housing a community of public and private researchers.
“Our significant investments in R&D, manufacturing and personnel reaffirm our commitment to Singapore as a hub for AB SCIEX global operations,” said Rainer Blair, president of AB SCIEX. “As a trusted partner with scientists all over the world, we will continue to drive new innovation and push the limits of analytical science.”
On the production side, AB SCIEX has completed the transfer of manufacturing Eksigent chromatography products from the US to Singapore. The physical expansion of manufacturing in its Marsiling factory in northern Singapore is part of a progressive plan for the Southeast Asian manufacturing operation to take on an increased number of products.
“Our proximity to Asia-Pacific customers creates greater opportunities for regional input into new products that can transform health and safety,” said KY Wong, vice president of Global Operations at AB SCIEX. “Also, by being in Singapore, we have strategic access to the Asian market’s supply chain resources.”
Source: AB SCIEX.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.